MARKET

CERC

CERC

Cerecor
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.370
+0.030
+0.90%
After Hours: 3.940 +0.57 +16.91% 19:41 09/20 EDT
OPEN
3.340
PREV CLOSE
3.340
HIGH
3.430
LOW
3.140
VOLUME
207.74K
TURNOVER
--
52 WEEK HIGH
7.65
52 WEEK LOW
2.710
MARKET CAP
144.60M
P/E (TTM)
-2.7789
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CERC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CERC News

  • Cerecor Amended 8-K Shows Nasdaq Notified Co. It Is Now In Compliance
  • Benzinga.2d ago
  • Daily Insider Ratings Round Up 9/6/19
  • Seeking Alpha - Article.09/09 21:08
  • Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy
  • Seeking Alpha - Article.08/28 14:26
  • 64 Biggest Movers From Yesterday
  • Benzinga.08/28 09:10

More

Industry

Biotechnology & Medical Research
+0.62%
Pharmaceuticals & Medical Research
+0.95%

Hot Stocks

Name
Price
%Change

About CERC

Cerecor, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment. The Company owns the rights to its COMTi platform. Catechol O methyltransferase (COMT) is an enzyme critical for the inactivation and metabolism of dopamine and its inhibition in the brain has applicability in treating subjects with neuropsychiatric conditions, including MDD, schizophrenia, Parkinson's disease and pathological gambling. Its COMTi platform comprises COMT inhibitors with selectivity for membrane bound COMT, which is the dominant form of COMT.
More

Webull offers Cerecor Inc (CERC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.